
Acuitas Therapeutics Inc, the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, is a Vancouver-based company collaborating with pharmaceutical and biotech companies, academic researchers, and global health organizations to advance a broad range of medicines for a variety of diseases. Acuitas’s clinically validated LNP technology has enabled two approved products, as well as 33 clinical trials in the last three years, including- COMIRNATY® for Covid-19 by Pfizer-BioNTech- ONPATTRO® for transthyretin amyloidosis by Alnylam Pharmaceuticals- First in-human…
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.